Back to top

Corporate Summary

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.


•    Shares of Ener1, Inc. (NASDAQ:HEV) plunged by 27.35%, after the company reported a large first-quarter net loss this week. Ener1 Inc. was also downgraded by Wunderlich Securities from "Hold" to "Sell" and its price target was reduced from $3.50 to $1.00

•    Global and federal government insurer American International Group, Inc (NYSE:AIG) revealed in a regulatory filing that they would sell 300 million shares to the public

•    Strong earnings results that grew more than three times in the first quarter helped share prices of the pipeline maker Northwest Pipe Co (NASDAQ:NWPX) surge 6.40% to close at $24.45

•    Internet portal Yahoo! Inc (NASDAQ:YHOO) reported that Alibaba Group has transferred ownership of its online payments business to an entity controlled by the CEO of Alibaba. Reacting to the news, shares of Yahoo fell 7.28% since the digital media company has a 43% stake in Alibaba

•    Conceptus, Inc.’s (NASDAQ:CPTS) share prices dropped 15.77% a day to close at $12.71 after the maker of a sterilization method reported a larger first-quarter loss beating the Street's projections

•    Oil and natural-gas company Harvest Natural Resources, Inc.’s (NYSE:HNR) share prices fell 6.99% after the company reported its first-quarter earnings results that fell short of expectations

•    Shares of Scientific Games Corp. (NASDAQ:SGMS) fell 2.56% after the maker of lottery tickets reported its first-quarter results that came in below consensus forecasts

•    Analysts at Goldman Sachs (NYSE:GS) initiated coverage on GNC Corp. with a “Neutral” rating and a target price of $22.00 citing the move as a valuation call

•    Johnson & Johnson (NYSE:JNJ) was upgraded by Goldman Sachs (NYSE:GS) to a "Buy" rating from "Neutral" rating. The brokerage firm also raised the target price of the company from $64 to $77

•    Bristol-Myers Squibb (NYSE:BMY) was downgraded by Goldman Sachs (NYSE:GS) from "Buy" to "Neutral" with a target price of $32 on the stock

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GRP IN DXYN 15.84 +7.90%
BOFI HLDG IN BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%